Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-27
DOI
10.3389/fimmu.2018.00382
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T Cell Dysfunction Acquiesces to BTLA+Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis
- (2016) Eduardo Huarte et al. JOURNAL OF IMMUNOLOGY
- CXCL13 is a plasma biomarker of germinal center activity
- (2016) Colin Havenar-Daughton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants
- (2015) Kevin Blauth et al. ACTA NEUROPATHOLOGICA
- B Cell Antigen Presentation Is Sufficient To Drive Neuroinflammation in an Animal Model of Multiple Sclerosis
- (2015) Chelsea R. Parker Harp et al. JOURNAL OF IMMUNOLOGY
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells
- (2013) Y. Ding et al. JOURNAL OF IMMUNOLOGY
- Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosis
- (2013) R Gopal et al. Mucosal Immunology
- Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell–dependent IgA responses
- (2013) Keiji Hirota et al. NATURE IMMUNOLOGY
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
- (2013) Ioannis Kalampokis et al. ARTHRITIS RESEARCH & THERAPY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
- (2011) Anneli Peters et al. IMMUNITY
- Functional and Epigenetic Studies Reveal Multistep Differentiation and Plasticity of In Vitro-Generated and In Vivo-Derived Follicular T Helper Cells
- (2011) Kristina T. Lu et al. IMMUNITY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Primary B-Cell Deficiencies Reveal a Link between Human IL-17-Producing CD4 T-Cell Homeostasis and B-Cell Differentiation
- (2011) Rita R. Barbosa et al. PLoS One
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Proinflammatory T helper type 17 cells are effective B-cell helpers
- (2010) M. Mitsdoerffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Serum levels of CXCL13 are elevated in active multiple sclerosis
- (2009) Eugene D Festa et al. Multiple Sclerosis Journal
- Bcl6 Mediates the Development of T Follicular Helper Cells
- (2009) R. I. Nurieva et al. SCIENCE
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor
- (2008) Inmaculada Rioja et al. ARTHRITIS AND RHEUMATISM
- Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis
- (2008) Christopher T. Harp et al. CLINICAL IMMUNOLOGY
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
- (2008) Mark A. Kroenke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started